Biopolym. Cell. 2006; 22(3):186-191.
http://dx.doi.org/10.7124/bc.00072F
Structure and Function of Biopolymers
Removal of part of the eEF1A GTP binding domain induced translation errors in vitro
1Pogribna A. P., 1Negrutskii B. S., 1Elskaya A. V.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680

Abstract

Eukaryotic translation elongation factor 1A (eEF1A) is one of the main components of the translation machinery acting at the elongation step. Oncogene PTI-1 which is expressed during prostate cancer development, codes the protein, homologous to eEF1A. In this paper the hypothesis is tested that the gene PTI-1 protein product can influence accuracy of translation. The ability of the PTI-1 protein analogue to stimulate misincorporation of leucine by ribosomes programmed with poly(U) was demonstrated. This finding favors the hypothesis about the ability of the PTI-1 oncogene product to influence translation accuracy in vivo.
Keywords: eukaryotic translation elongation factor 1A, oncogene PTI-1, ribosome, tRNA
Full text: (PDF, in English) (PDF, in Ukrainian)

References

[1] Yang W, Boss WF. Regulation of phosphatidylinositol 4-kinase by the protein activator PIK-A49. Activation requires phosphorylation of PIK-A49. J Biol Chem. 1994;269(5):3852-7.
[2] Shiina N, Gotoh Y, Kubomura N, Iwamatsu A, Nishida E. Microtubule severing by elongation factor 1 alpha. Science. 1994;266(5183):282-5.
[3] Kurasawa Y, Hanyu K, Watanabe Y, Numata O. F-actin bundling activity of Tetrahymena elongation factor 1 alpha is regulated by Ca2+/calmodulin. J Biochem. 1996;119(4):791-8.
[4] Ruest LB, Marcotte R, Wang E. Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J Biol Chem. 2002;277(7):5418-25.
[5] Grant AG, Flomen RM, Tizard MLV, Grant DAW. Differential screening of a human pancreatic adenocarcinoma ?gt11 expression library has identified increased transcription of elongation factor ef-1? in tumour cells. Int J Cancer . 1992;50(5):740-5.
[6] Edmonds BT, Wyckoff J, Yeung YG, Wang Y, Stanley ER, Jones J, Segall J, Condeelis J. Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci. 1996;109 ( Pt 11):2705-14.
[7] Cimarelli A, Luban J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol. 1999;73(7):5388-401.
[8] Reynet C, Kahn CR. Unbalanced expression of the different subunits of elongation factor 1 in diabetic skeletal muscle. Proc Natl Acad Sci U S A. 2001;98(6):3422-7.
[9] Ejiri S. Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci Biotechnol Biochem. 2002;66(1):1-21. Review.
[10] Shen R, Su ZZ, Olsson CA, Fisher PB. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci U S A. 1995;92(15):6778-82.
[11] Mansilla F, Hansen LL, Jakobsen H, Kjeldgaard NO, Clark BF, Knudsen CR. Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, form of translation elongatin factor 1A1, eEF1A1. Biochim Biophys Acta. 2005;1727(2):116-24.
[12] Su Z, Goldstein NI, Fisher PB. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci U S A. 1998;95(4):1764-9.
[13] Gopalkrishnan RV, Su ZZ, Goldstein NI, Fisher PB. Translational infidelity and human cancer: role of the PTI-1 oncogene. Int J Biochem Cell Biol. 1999;31(1):151-62.
[14] Sandbaken MG, Culbertson MR. Mutations in elongation factor EF-1 alpha affect the frequency of frameshifting and amino acid misincorporation in Saccharomyces cerevisiae. Genetics. 1988;120(4):923-34.
[15] Pogribna AP, Gorchakov SV, Negrutskii BS. Comparative analysis of the functional activity of the native and modified by trypsin forms of eukaryotic translation elongation factor 1a. Biopolym Cell. 2004; 20(4):300-6.
[16] El'skaya AV, Ovcharenko GV, Palchevskii SS, Petrushenko ZM, Triana-Alonso FJ, Nierhaus KH. Three tRNA binding sites in rabbit liver ribosomes and role of the intrinsic ATPase in 80S ribosomes from higher eukaryotes. Biochemistry. 1997;36(34):10492-7.
[17] Agafonov DE, Spirin AS. The ribosome-associated inhibitor A reduces translation errors. Biochem Biophys Res Commun. 2004;320(2):354-8.
[18] El'skaya AV, Soldatkin AP. The accuracy of poly(U) translation by different eukaryotic tRNAs. FEBS Lett. 1983;164(1):93-6.
[19] Abbott CM, Proud CG. Translation factors: in sickness and in health. Trends Biochem Sci. 2004;29(1):25-31.
[20] Cavallius J, Merrick WC. Site-directed mutagenesis of yeast eEF1A. Viable mutants with altered nucleotide specificity. J Biol Chem. 1998;273(44):28752-8.
[21] Carr-Schmid A, Durko N, Cavallius J, Merrick WC, Kinzy TG. Mutations in a GTP-binding motif of eukaryotic elongation factor 1A reduce both translational fidelity and the requirement for nucleotide exchange. J Biol Chem. 1999;274(42):30297-302.
[22] Vitagliano L, Ruggiero A, Masullo M, Cantiello P, Arcari P, Zagari A. The crystal structure of Sulfolobus solfataricus elongation factor 1alpha in complex with magnesium and GDP. Biochemistry. 2004;43(21):6630-6.
[23] Kinzy TG, Merrick WC. Characterization of a limited trypsin digestion form of eukaryotic elongation factor 1 alpha. J Biol Chem. 1991;266(7):4099-105.